Literature DB >> 16940391

Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy.

Juan Pablo Kaski, María Teresa Tomé Esteban, Martin Lowe, Simon Sporton, Philip Rees, John E Deanfield, William J McKenna, Perry M Elliott.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16940391      PMCID： PMC1861462          DOI： 10.1136/hrt.2006.094730

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; W K Shen; M S Link; A E Epstein; A K Almquist; J P Daubert; G H Bardy; S Favale; R F Rea; G Boriani; N A Estes; P Spirito
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

2.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Authors:  P M Elliott; J Poloniecki; S Dickie; S Sharma; L Monserrat; A Varnava; N G Mahon; W J McKenna
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

Review 3.  Management of hypertrophic cardiomyopathy in children.

Authors:  Hubert Seggewiss; Angelos Rigopoulos
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.

Authors:  Thomas Korte; Harald Köditz; Michael Niehaus; Thomas Paul; Jürgen Tebbenjohanns
Journal:  Pacing Clin Electrophysiol       Date:  2004-07       Impact factor: 1.976

5.  Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.

Authors:  M J Silka; J Kron; A Dunnigan; M Dick
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690
  5 in total
  21 in total

1.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

2.  Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study.

Authors:  Gabrielle Norrish; Henry Chubb; Ella Field; Karen McLeod; Maria Ilina; Georgia Spentzou; Jan Till; Piers E F Daubeney; Alan Graham Stuart; Jane Matthews; Dominic Hares; Elspeth Brown; Katie Linter; Vinay Bhole; Krishnakumar Pillai; Michael Bowes; Caroline B Jones; Orhan Uzun; Amos Wong; Arthur Yue; Shankar Sadagopan; Tara Bharucha; Norah Yap; Eric Rosenthal; Sujeev Mathur; Satish Adwani; Zdenka Reinhardt; Jasveer Mangat; Juan Pablo Kaski
Journal:  Europace       Date:  2021-03-08       Impact factor: 5.214

3.  Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease.

Authors:  Nicholas H Von Bergen; Dianne L Atkins; Macdonald Dick; David J Bradley; Susan P Etheridge; Elizabeth V Saarel; Peter S Fischbach; Seshadri Balaji; Narayanswami Sreeram; William N Evans; Ian H Law
Journal:  Pediatr Cardiol       Date:  2011-01-06       Impact factor: 1.655

4.  ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

Authors:  Amar Trivedi; Bradley P Knight
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

5.  Exercise Recommendations in Pediatric HCM: Variation and Influence of Provider Characteristics.

Authors:  Robert D Whitehill; Seshadri Balaji; Michael Kelleman; Stephanie F Chandler; Dominic J Abrams; Chad Mao; Peter Fischbach; Robert Campbell
Journal:  Pediatr Cardiol       Date:  2021-08-18       Impact factor: 1.655

6.  Therapeutic options in hypertrophic cardiomyopathy: a pediatric perspective.

Authors:  Edward K Rhee; John J Nigro; Stephen G Pophal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

Review 7.  Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.

Authors:  Sabine Huke; Björn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2010-01-22       Impact factor: 5.000

8.  Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

Authors:  Franz Baudenbacher; Tilmann Schober; Jose Renato Pinto; Veniamin Y Sidorov; Fredrick Hilliard; R John Solaro; James D Potter; Björn C Knollmann
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

9.  Implanted defibrillators in young hypertrophic cardiomyopathy patients: a multicenter study.

Authors:  Anna N Kamp; Nicholas H Von Bergen; Charles A Henrikson; Majd Makhoul; Elizabeth V Saarel; Martin J Lapage; Mark W Russell; Margaret Strieper; Sunkyung Yu; Macdonald Dick; Sharlene M Day; David J Bradley
Journal:  Pediatr Cardiol       Date:  2013-03-20       Impact factor: 1.655

Review 10.  Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere.

Authors:  Gabrielle Norrish; Ella Field; Juan P Kaski
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.